Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.
出版信息
PLoS One. 2019 Jul 23;14(7):e0220418. doi: 10.1371/journal.pone.0220418. eCollection 2019.
Abstract
摘要
相似文献
1
Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.撤稿：基于中性粒细胞与淋巴细胞比值的评分模型预测肝移植术后HBV相关肝细胞癌的复发
PLoS One. 2019 Jul 23;14(7):e0220418. doi: 10.1371/journal.pone.0220418. eCollection 2019.
2
Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection.中性粒细胞与淋巴细胞比值可预测乙型肝炎病毒感染患者射频消融术后的复发情况。
J Gastroenterol Hepatol. 2016 Jul;31(7):1291-9. doi: 10.1111/jgh.13287.
3
Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization.单核细胞/粒细胞与淋巴细胞比值及终末期肝病模型（MELD）评分作为经动脉化疗栓塞术后肝细胞癌早期复发的预测指标
Br J Biomed Sci. 2018 Oct;75(4):187-191. doi: 10.1080/09674845.2018.1494769. Epub 2018 Aug 21.
4
Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation.乙肝表面抗原阳性肝硬化患者肝移植后乙肝再感染的风险。原发性肝细胞癌并非乙肝复发的预测因素。欧洲肝癌与移植合作研究组。
Liver. 1996 Apr;16(2):117-22. doi: 10.1111/j.1600-0676.1996.tb00715.x.
5
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
6
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.一种新型预后列线图可准确预测肝移植后肝细胞癌复发：对865例连续肝移植受者的分析
J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.
7
Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.术后中性粒细胞与淋巴细胞比值联合血小板与淋巴细胞比值可预测肝细胞癌患者的预后。
J Surg Res. 2015 Sep;198(1):73-9. doi: 10.1016/j.jss.2015.05.003. Epub 2015 May 7.
8
[Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma].[术前中性粒细胞与淋巴细胞比值作为肝细胞癌肝移植术后的预后预测指标]
Zhonghua Yi Xue Za Zhi. 2011 Jun 14;91(22):1519-22.
9
Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.肝移植后乙型肝炎表面抗原阳性患者的肝细胞癌复发和乙型肝炎再感染。
Liver Transpl. 2009 Nov;15(11):1525-34. doi: 10.1002/lt.21882.
10
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.乙型肝炎和丙型肝炎相关肝细胞癌手术治疗效果的差异：单一大西洋彼岸中心的回顾性分析。
Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.
本文引用的文献
1
Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.中国涉及器官移植的同行评审出版物中报告供体来源和伦理审查的道德标准遵循情况：范围综述。
BMJ Open. 2019 Feb 5;9(2):e024473. doi: 10.1136/bmjopen-2018-024473.
2
A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.基于中性粒细胞与淋巴细胞比值的评分模型预测乙肝相关性肝细胞癌肝移植术后复发。
PLoS One. 2011;6(9):e25295. doi: 10.1371/journal.pone.0025295. Epub 2011 Sep 26.
Zotero 插件